ARMISTICE CAPITAL, LLC

Q3 2020 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2020
Date filed
11/16/2020
Form type
13F-HR
Num holdings
101
Total value ($000)
$2,756,669
Net value change ($000)
+476,753 (20.9%)
New positions
41
Sold out positions
23
Turnover %
36.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2020 Next filing: 2/16/2021 SEC filing

Snapshot: Change Analysis

Compared to Q2 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
WSM 40,246 NEW
ALKERMES PLC 35,195 NEW
KO 31,992 NEW
SPECTRUM PHARMACEUTICALS INC 30,894 NEW
AZO 28,815 91.2%
DKS 24,310 NEW
BNTX 23,261 NEW
CPB 22,668 104.8%
Biohaven Pharmaceutical Holding Co Ltd. 21,954 60.1%
NUVASIVE INC 21,857 NEW
Top Reduces (Value $000, Stocks/ETFs)
DBX -35,354 -100.0%
DG -35,325 -100.0%
ATR -32,250 -100.0%
BIIB -29,423 -50.9%
BBY -28,967 -100.0%
BURL -28,627 -100.0%
CMG -25,257 -100.0%
FIVE -24,640 -61.0%
WOO -23,758 -100.0%
KFY -21,880 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 611,936 (22.2% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type